RIVERA VICTOR enters THESEUS PHARMACEUTICALS, INC. with 388.32K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/6/2021ACC: 0000899243-21-039499
Officer· Chief Scientific Officer
Since Oct 2021
388.32K
Baseline shares
100% direct
388.32K
Direct ownership
1 position
441.96K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned388.32K
Total
388.32K direct388.32K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 388.32K | Direct |
| Total | 388.32K | 388.32K direct |
Derivative Holdings3
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
36.07K
Shares owned
N/A
Exercise price
4.0347
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
344.34K
Shares owned
N/A
Exercise price
0.3175
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
61.55K
Shares owned
N/A
Exercise price
4.0347
Expiration
—
Exercise window
—
Total
Underlying
441.96K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 4.0347 | — | — | 36.07K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 0.3175 | — | — | 344.34K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 4.0347 | — | — | 61.55K | N/A |
| Total | 441.96K | 0.00 | ||||